Rosiglitazone-induced reductions inNADPH oxidase activity in a rat model of hypertension furthersupport the potential of PPARγ ligands to favorablymodulate dysregulated reactive oxygen species production[62]. The gene discussed is PPARG; the disease is hypertensive disorder.